However, the recent implementation of serum AAT dosage and SERPINA-1 genetic testing in patients affected by several respiratory diseases or unexplained dyspnea has increased the detection not only of the already known deficient variants, but also of the new rare PI* alleles [16,23]. The gene discussed is SERPINA1; the disease is respiratory system disorder.